NATIONAL ORGANIZATION FOR RARE DISORDERS, INC. (NORD) for NATIONAL ORGANIZATION FOR RARE DISORDERS INC (NORD)
What was lobbied
4 issue areas, each in the filer's own words, with who lobbied on it and where.
Budget/Appropriations BUD
Appropriations for patients with rare diseases. Food and Drug Administration Appropriations. National Institutes of Health (NIH) Appropriations. CDC Appropriations.
| Lobbyist | Covered position, as disclosed |
|---|---|
| MICHELLE ADAMS | — |
| MELANIE SWICK BUZZELLI | — |
Health Issues HCR
Health issues impacting patients with rare diseases. H.R.4228: Rare disease Advancement, Surveillance Research, and Education (RARE) Act of 2019. Rare Disease Day Resolution. NIH Rare Disease Day. FDA Rare Disease Day. Rare Cancer. Step Therapy. H.R.2279/S.2546: Safe Step Act. Newborn Screening. H.R.2507/S.2158: Newborn Screening Saves Lives Reauthorization Act of 2019. H.R.1379/S.560: Ensuring Lasting Smiles Act. Pediatric Research Equity Act (PREA). Biosimilars. Individualized Therapies. Genetic Testing. Gene Therapy. Medical Foods. Public Law No: 111-148: The Patient Protection and Affordable Care Act. CMS-9916-P: Patient Protection and Affordable Care Act; HHS Notice of Benefit and Payment Parameters for 2021; Notice Requirement for Non-Federal Governmental Plans. S.1895: Lower Health Care Costs Act. Surprise Medical Billing. COVID-19 Related Issues. H.R.748/S.3548: Coronavirus Aid, Relief, and Economic Security Act (CARES) Act.
| Lobbyist | Covered position, as disclosed |
|---|---|
| MICHELLE ADAMS | — |
| RACHEL L. SHER | — |
| MELANIE SWICK BUZZELLI | — |
Medicare/Medicaid MMM
Medicare issues impacting patients with rare diseases. Medicare Part D Program. CMS-2324-NC: Request for Information on Coordinating Care from Out-of-State Providers for Medicaid-eligible Children with Medically Complex Conditions. Social Security Administration (SSA) Continuing Disability Reviews.
| Lobbyist | Covered position, as disclosed |
|---|---|
| MICHELLE ADAMS | — |
| MELANIE SWICK BUZZELLI | — |
Pharmacy PHA
Pharmaceutical issues impacting patients with rare diseases. Orphan Drug Act. Drug Pricing. H.R.3: Elijah E. Cummings Lower Drug Costs Now Act. FDA Patient-Focused Drug Development (PFDD) Draft Guidance. Importation Issues. FDA-2019-D-5743: Importation of Certain Food and Drug Administration-Approved Human Prescription Drugs, Including Biological Products, Under Section 801(d)(1)(B) of the Federal Food, Drug, and Cosmetic Act; Draft Guidance for Industry; Availability. H.R.5497/S.3133: Conditional Approval Act.
| Lobbyist | Covered position, as disclosed |
|---|---|
| MICHELLE ADAMS | — |
| RACHEL L. SHER | — |
| MELANIE SWICK BUZZELLI | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.